2015-05-07T12:20:14-05:00 2014-06-30 390859910 BAKER TILLY VIRCHOW KRAUSE LLP 1650 MARKET STREET SUITE 4500 PHILADELPHIA PA 19103 990 2013-07-01 210672684 CORIELL INSTITUTE FOR MEDICAL RESEARCH INC CORI 8567574828 403 HADDON AVENUE CAMDEN NJ 08103 CONSTANTINE STOIOS CFO 8567574828 2015-05-07 1 JULIUS GREEN CPA JD P00350393 2159720701 2013 2016-03-07 17:11:31Z CONSTANTINE STOIOS 403 HADDON AVENUE CAMDEN NJ 08103 18638047 0 X WWW.CORIELL.ORG X 1953 NJ BIOMEDICAL RESEARCH ORGANIZATION DEDICATED TO UNDERSTANDING HUMAN GENETIC DISEASES. 19 18 137 18 0 0 1231553 1468533 18937358 16854195 151957 170232 158312 125630 20479180 18618590 0 0 0 0 10152616 10466269 0 0 125619 10381409 9876680 20534025 20342949 -54845 -1724359 38815940 37878126 11103046 11597080 27712894 26281046 X THE CORIELL INSTITUTE FOR MEDICAL RESEARCH SEEKS TO DISCOVER THE CAUSES OF CANCER AND OTHER GENETIC DISEASES IN ORDER TO IMPROVE THE HEALTH OF HUMANKIND, THROUGH SCIENTIFIC RESEARCH, BANKING OF CELL AND TISSUES, AND EDUCATION. 0 0 15690847 0 16854195 CORIELL INSTITUTE FOR MEDICAL RESEARCH, FOUNDED IN 1953 AND BASED IN CAMDEN, NEW JERSEY, IS AN INDEPENDENT NON-PROFIT RESEARCH INSTITUTE DEDICATED TO THE STUDY OF THE HUMAN GENOME. EXPERT STAFF AND PIONEERING PROGRAMS IN THE FIELDS OF PERSONALIZED MEDICINE, CELL BIOLOGY, CYTOGENETICS, GENOTYPING, AND BIOBANKING DRIVE OUR MISSION. THE INSTITUTE MAINTAINS REPOSITORIES FOR CELL LINES AND DNA AND DISTRIBUTES OVER 20,000 BIOMATERIALS ANNUALLY TO RESEARCHERS NATIONALLY AND INTERNATIONALLY.THE CORIELL PERSONALIZED MEDICINE COLLABORATIVE (CPMC) RESEARCH STUDY IS SEEKING TO UNDERSTAND THE USEFULNESS OF GENETIC RISK AND PHARMACOGENOMICS IN CLINICAL DECISION-MAKING AND HEALTHCARE MANAGEMENT.CORIELL HAS A DISTINGUISHED HISTORY IN CELL BIOLOGY, PURSUING CURRENTLY INDUCED PLURIPOTENT STEM (IPS) CELL RESEARCH. THESE POWERFUL CELLS ARE REVOLUTIONIZING THE WAY HUMAN DISEASE IS STUDIED AND HOW DRUGS ARE DEVELOPED. CORIELL OFFERS CUSTOM RESEARCH SERVICES INCLUDING CELL CULTURE, CYTOGENETIC ANALYSES, AND MOLECULAR BIOLOGY. ITS CLIA-CERTIFIED GENOTYPING AND MICROARRAY CENTER OFFERS HIGH-THROUGHPUT DNA ANALYSIS SYSTEMS USING THE PLATFORMS OF TWO LEADING PROVIDERS.ESSENTIAL TO THE INSTITUTE'S SUPPORT OF INTERNATIONAL SCIENTIFIC RESEARCH IS THE CORIELL BIOBANK. FROM THIS RENOWNED CELL BANK, CORIELL MANAGES AND DISTRIBUTES THE WORLD'S MOST DIVERSE COLLECTION OF CELL LINES, DNA, AND OTHER BIOLOGICAL RESOURCES. THE CORIELL BIOBANK PROVIDED SUPPORT TO THE HUMAN GENOME PROJECT, A WORLDWIDE PROGRAM TO MAP THE ENTIRE HUMAN GENOME, AND TO THE INTERNATIONAL HAPMAP PROJECT, A PROJECT PROVIDING AN EFFICIENT TOOL TO IDENTIFY DISEASE-CAUSING GENES.CORIELL'S BIOBANKING OPERATION IS FUNDED BY SEVERAL NATIONAL INSTITUTES OF HEALTH AWARDS. 15690847 1 1 0 1 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 1 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 55 0 1 137 1 0 0 0 0 0 0 0 0 0 0 X 19 18 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 1 NJ PA NY CA X CONSTANTINE STOIOS CFO 8567574828 403 HADDON AVENUE CAMDEN NJ 08103 MICHAEL F CHRISTMAN PHD PRESIDENT & CEO/SECRETARY 40.00 X X 485726 0 23865 PETER DRISCOLL ESQ TRUSTEE 1.00 X 0 0 0 JOANNE FREDERICKS TRUSTEE 1.00 X 0 0 0 DAVID FRIEDMAN TRUSTEE 1.00 X 0 0 0 LIESL HENDERSON TRUSTEE 1.00 X 0 0 0 ROBERT KIEP III BOARD CHAIR 1.00 X X 0 0 0 CALVIN KNOWLTON PHD TRUSTEE 1.00 X 0 0 0 STEPHEN KOPLIN TRUSTEE 1.00 X 0 0 0 CHARLES LORD TRUSTEE 1.00 X 0 0 0 CONSTANCE MADARA TRUSTEE 1.00 X 0 0 0 MICHAEL L SANYOUR TRUSTEE 1.00 X 0 0 0 MARC MASER ESQ TRUSTEE 1.00 X 0 0 0 NEWBOLD STRONG TRUSTEE 1.00 X 0 0 0 EDWARD VINER MD TRUSTEE 1.00 X 0 0 0 JERRY JOHNSON TRUSTEE 1.00 X 0 0 0 NICHOLAS KOVICH TRUSTEE 1.00 X 0 0 0 WADIA MULLA MD TRUSTEE 1.00 X 0 0 0 FRANK GIORDANO TRUSTEE 1.00 X 0 0 0 ARNAUD BASTIEN MD TRUSTEE 1.00 X 0 0 0 JOSEPH L MINTZER EVP & COO/TREASURER 40.00 X 293719 0 36434 STEVEN J MADORE PHD DIRECTOR, BIOBANKING 40.00 X 162713 0 38668 JOAN MCMANUS PRIOR DIRECTOR OF FINANCE 40.00 X 117259 0 9083 NORMAN P GERRY PHD DIRECTOR-GENOTYPING/MICROARRAY 40.00 X 134935 0 15178 COURTNEY KRONENTHAL DIR, COMMUNICATIONS & DEVELOP. 40.00 X 135015 0 22124 MARK BELLAFANTE DIR., INFORMATION TECHNOLOGY 40.00 X 145893 0 29058 CHI TARN PHD PRINCIPAL INVESTIGATOR, NINDS 40.00 X 127664 0 28129 SUSAN DELANEY DIRECTOR, GOV'T AFFAIRS AND POLICY 40.00 X 123544 0 9215 1726468 0 211754 16 0 1 0 CELLULAR DYNAMICS INTERNATIONAL 525 SCIENCE DRIVE MADISON WI 53711 CONSULTING 162861 ARCHER & GREINER PC 33 E EUCLID AVENUE HADDONFIELD NJ 08033 LEGAL SVC. 114878 BIONIQUE TESTING LABS INC 156 FAY BROOK LN SARANAC LAKE NY 12983 LAB TESTING 107182 3 12641 1037000 418892 1468533 GOVT FEES & CONTRACTS 621500 12278789 12278789 NON-GOVERNMENT REPOSITORY SERVICE 621500 3582522 3582522 INVESTIGATOR DIRECTED SCIENCE 621500 992884 992884 16854195 182606 182606 7083 7083 0 12374 -12374 -12374 -12374 SPECIAL EVENT REVENUE 900099 66315 66315 REDUCTION OF CAPITAL LEASE 900099 59137 59137 MISCELLANEOUS INCOME 900099 178 178 125630 18618590 16854195 0 295862 1035449 1035449 7062639 5800319 1262320 438450 381884 56566 1377732 1000705 377027 551999 421615 130384 134470 134470 77084 77084 40910 40910 1673077 983800 563658 125619 3125846 3104246 21600 2892414 2439205 453209 145572 95434 50138 1787307 1463639 323668 20342949 15690847 4526483 125619 1200 1200 2097563 333737 3239523 3207106 1624818 2492976 183500 163500 137737 75999 496926 655988 30610107 19903800 11246542 10706307 6427603 7634237 13360528 12607076 38815940 37878126 1279124 1497207 30000 520352 3988191 3257625 4908517 4772575 897214 1549321 11103046 11597080 X 12857820 10999277 14038496 14465191 816578 816578 27712894 26281046 38815940 37878126 X -1724359 824936 -532425 X 0 1 X 1 1 1 X 1696487 3652779 3330518 1231553 2523357 12434694 1696487 3652779 3330518 1231553 2523357 12434694 754030 11680664 176017 100684 218218 147671 189689 832279 49657 18090 17871 158312 59315 303245 13570218 80837129 0.86080 0.80390 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS INCOME - 2009 AMOUNT: $ 30,407. 2010 AMOUNT: $ 190. 2011 AMOUNT: $ 121. 2012 AMOUNT: $ 3,312. 2013 AMOUNT: $ 178. CAPITAL LEASE REDUCTION - 2013 AMOUNT: $ 59,137. SCIENCE FAIR - 2009 AMOUNT: $ 19,250. 2010 AMOUNT: $ 17,900. 2011 AMOUNT: $ 17,750. MEDICAL SCHOOL CURRICULUM DESIGN - 2012 AMOUNT: $ 155,000. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 40910 40910 20827676 20868586 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 38750 45050 43350 40910 168060 250000 250000 250000 250000 1000000 1500000 6427603 208295 998339 7634237 5411350 173504 842749 6427603 5601595 10189 -200434 5411350 6915104 239008 998335 2549198 1654 5601595 8686542 878716 2618000 32154 6915104 0.33000 0.56300 0.10700 0 0 245000 245000 11723779 11542437 181342 2114974 1558867 556107 16526354 6802496 9723858 10706307 NEW JERSEY CORD BLOOD BANK 4684350 USE OF RESEARCH FACILITY 6912563 SPLIT-INTEREST AGREEMENTS 930652 OTHER MISCELLANEOUS ASSETS 4185 DEFERRED FINANCING COSTS, NET 75326 12607076 ADVANCES ON HAND 510347 DERIVATIVE FINANCIAL INSTRUMENT 188269 HOLDING ACCOUNTS 850705 1549321 X 20170407 824936 652275 67523 1544734 18625673 -7083 -7083 18618590 21602255 652275 607031 1259306 20342949 0 20342949 PART V, LINE 4: THE INSTITUTE'S ENDOWMENT FUNDS ARE USED TO SUPPORT THE SHORT AND LONG TERM GOALS OF THE INSTITUTE. THE INSTITUTE HAS AN APPROVED SPENDING RATE OF 4.0% FOR BOTH 2014 AND 2013 TO DETERMINE THE AMOUNT OF ENDOWMENT EARNINGS TO BE ALLOCATED TO OPERATIONS FROM INTERNALLY MANAGED ENDOWMENTS. THE SPENDING RATE, WHICH IS SUBJECT TO REVIEW BY THE INSTITUTE'S BOARD OF TRUSTEES, IS APPLIED TO A MOVING AVERAGE OF ANNUAL ENDOWMENT LEVELS OVER THE PRIOR THREE YEARS. AT ITS DISCRETION THE BOARD MAY APPROVE DRAWS OF ADDITIONAL FUNDS ABOVE THE SPENDING RATE TO SUPPORT SPECIFIC GOALS OF THE INSTITUTE. THE INSTITUTE DID NOT DRAW OR TRANSFER ANY FUNDS DURING THE YEARS ENDING JUNE 30, 2014 OR 2013. PART X, LINE 2: THE INSTITUTE ACCOUNTS FOR UNCERTAINTY IN INCOME TAXES USING A RECOGNITION THRESHOLD OF MORE-LIKELY-THAN NOT TO BE SUSTAINED UPON EXAMINATION BY THE APPROPRIATE TAXING AUTHORITY. MEASUREMENT OF THE TAX UNCERTAINTY OCCURS IF THE RECOGNITION THRESHOLD HAS BEEN MET. MANAGEMENT DETERMINED THAT THERE WERE NO TAX UNCERTAINTIES THAT MET THE RECOGNITION THRESHOLD IN 2014 AND 2013. THE INSTITUTE'S FEDERAL EXEMPT ORGANIZATION BUSINESS INCOME TAX RETURNS FOR YEARS ENDED JUNE 30, 2013, 2012 AND 2011 REMAIN SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE. PART XI, LINE 2D - OTHER ADJUSTMENTS: CHANGE IN VALUE OF SPLIT-INTEREST AGREEMENTS 60,622. CHANGE IN VALUE OF FUTURE BUILDING OCCUPANCY -81,072. CHANGE IN VALUE OF DERIVATIVE FINANCIAL INSTRUMENT 87,973. PART XI, LINE 4B - OTHER ADJUSTMENTS: RENTAL EXPENSES -7,083. PART XII, LINE 2D - OTHER ADJUSTMENTS: RENTAL EXPENSES 7,083. CORIELL LIFE SCIENCE EXPENSES 599,948. EUROPE 0 0 LICENSING TECHNOLOGY THERE IS NO ACTIVITY IN FOREIGN REGIONS. THE ORGANIZATION RECEIVES ROYALTIES FOR SHARED MEDICAL TECHNOLOGY WITH AN ITALIAN BIO-TECH FIRM. AFRICA 0 0 CONSULTING THE ORGANIZATION HAS A CONSULTING AGREEMENT WITH THE INSTITUTE OF HUMAN VIROLOGY NIGERIA, A CORPORATION ORGANIZED AND EXISTING UNDER THE LAWS OF NIGERIA. DURING THE MOST RECENT FISCAL YEAR, REPORTED EXPENSES WERE RELATED TO EMPLOYEE TRAVEL TO NIGERIA FOR CONSULTING PURPOSES. 10174 0 0 0 0 0 0 10174 0 10174 0 0 0 0 0 0 X X X X X 0 1 0 0 0 0 0 1 0 MICHAEL F CHRISTMAN PHD PRESIDENT & CEO/SECRETARY 445726 0 40000 0 0 0 17850 0 6015 0 509591 0 0 0 JOSEPH L MINTZER EVP & COO/TREASURER 268719 0 25000 0 0 0 17850 0 18584 0 330153 0 0 0 STEVEN J MADORE PHD DIRECTOR, BIOBANKING 162713 0 0 0 0 0 17850 0 20818 0 201381 0 0 0 NORMAN P GERRY PHD DIRECTOR-GENOTYPING/MICROARRAY 134935 0 0 0 0 0 9601 0 5577 0 150113 0 0 0 COURTNEY KRONENTHAL DIR, COMMUNICATIONS & DEVELOP. 125015 0 10000 0 0 0 9884 0 12240 0 157139 0 0 0 MARK BELLAFANTE DIR., INFORMATION TECHNOLOGY 140893 0 5000 0 0 0 10489 0 18569 0 174951 0 0 0 CHI TARN PHD PRINCIPAL INVESTIGATOR, NINDS 127664 0 0 0 0 0 9148 0 18981 0 155793 0 0 0 PART I, LINE 4B THE INSTITUTE HAD A SUPPLEMENTAL RETIREMENT PLAN FOR JOSEPH L. MINTZER, EXECUTIVE VICE-PRESIDENT/COO, THE VALUE OF WHICH WAS TO BE PAID IN A SINGLE LUMP SUM TO THE EXECUTIVE OR HIS BENEFICIARY UPON ONE OF THE FOLLOWING (1) 62ND BIRTHDAY, (2) INVOLUNTARY TERMINATION, (3) TOTAL DISABILTIY, OR (4) DEATH. THE EXECUTIVE TURNED 62 IN FEBRUARY 2014. THE VALUE OF THE ACCOUNT IN FEBRUARY WAS $174,788.42, WHICH WAS PAID IN A SINGLE LUMP SUM AMOUNT TO THE EXECUTIVE. PART I, LINE 7 THE COMPENSATION COMMITTEE DETERMINES BONUSES FOR OFFICERS AND KEY EMPLOYEES BASED UPON VARIOUS PERFORMANCE CRITERIA. A THE CAMDEN COUNTY IMPROVEMENT AUTHORITY 222681222 2008-07-02 6000000 FINANCE THE RENOVATION OF LABORATORY/OFFICE SPACE AND PURCHASE EQUIPMENT 0 0 0 A 2742375 6000000 119000 5881000 2010 0 0 1 1 A 0 0 0 0 0 0 1 A 0 0 1 0 1 1 TD BANK 10.000000000000 0 0 0 0 1 A 1 FORM 990, SCHEDULE K, PART III, LINE 3C THE ORGANIZATION IS A RESEARCH FACILITY WHICH DOES NOT HAVE RENTAL AGREEMENTS OR SERVICE CONTRACTS THAT CONSTITUTE A CONTRACT WHICH MIGHT RESULT IN PRIVATE BUSINESS USE. SHOULD THE ORGANIZATION ENTER INTO AN AGREEMENT THAT WOULD NECESSITATE THE REVIEW OF BOND COUNSEL, IT WOULD TAKE ALL NECESSARY STEPS TO ENSURE THAT ALL SAFE HARBOR REQUIREMENTS WERE MET. M CHRISTMAN PHD TRUSTEE/PRESIDENT AND CEO PURCHASE PROPERTY X 250000 163500 0 1 1 163500 FORM 990, PART VI, SECTION A, LINE 1 THE EXECUTIVE COMMITTEE MAY ACT ON BEHALF OF THE BOARD OF TRUSTEES WHEN THE BOARD IS NOT IN SESSION. FORM 990, PART VI, SECTION A, LINE 2 ONE OF CORIELL'S BOARD TRUSTEES (N. KOVICH) WORKS FOR A FIRM THAT PREPARES CORIELL'S INVESTMENT PORTFOLIO REPORT. TWO BOARD TRUSTEES (N. STRONG AND J. FREDERICKS) ARE EMPLOYED AT THE SAME FIRM (PA TRUST). CORIELL'S CHAIR OF BOARD OF TRUSTEES (R. KIEP) IS A BOARD MEMBER OF A COMPANY PRIMARILY OWNED BY P. DRISCOLL (CORIELL BOARD TRUSTEE). CORIELL LIFE SCIENCES, INC., A NEWLY CREATED C-CORP AND SPIN-OFF FOR-PROFIT ORGANIZATION FROM CORIELL INSTITUTE FOR MEDICAL RESEARCH, WAS PRIMARILY CONTROLLED BY THE CORIELL INSTITUTE FOR MEDICAL RESEARCH DURING FY 2014 (6/30/14). DURING FY 2014 (6/30/14), CORIELL LIFE SCIENCES, INC. RECEIVED INVESTMENTS (BEGINNING IN JANUARY 2014) BUT DID NOT GENERATE ANY REVENUE DURING FY 2014. FORM 990, PART VI, SECTION B, LINE 11 THE CHAIR OF THE AUDIT COMMITTEE REVIEWS THE FORM 990 AND PRESENTS ITS CONTENTS TO MEMBERS OF THE AUDIT AND EXECUTIVE COMMITTEES. THE FORM IS DISTRIBUTED TO ALL CORIELL TRUSTEES BEFORE FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE CEO ANNUALLY DISTRIBUTES THE CONFLICT OF INTEREST POLICY AND DISCLOSURE STATEMENT TO EACH MEMBER OF THE BOARD OF TRUSTEES. EACH TRUSTEE MUST COMPLETE AND RETURN THE ANNUAL DISCLOSURE STATEMENT TO THE CEO ON A TIMELY BASIS. HE OR SHE MUST TIMELY INFORM THE CEO AND/OR THE COMMITTEE OF ANY POTENTIAL OR ACTUAL CONFLICT OF INTEREST OR OF ANY SITUATION WHICH MIGHT LEAD TO THE APPEARANCE OF A CONFLICT OF INTEREST. IN ADDITION, THE CHIEF FINANCIAL OFFICER (CF0) ANNUALLY DISTRIBUTES A COPY OF THE EMPLOYEE CONFLICT OF INTEREST POLICY AND DISCLOSURE STATEMENT TO EACH OFFICER, EXECUTIVE, AND APPROPRIATE EMPLOYEE. THESE EMPLOYEES ARE REQUIRED TO SUBMIT THE COMPLETED DISCLOSURE STATEMENT TO THE CFO AND DISCLOSE ANY POTENTIAL OR ACTUAL CONFLICT OF INTEREST. REPORTED CONFLICTS OF INTEREST ARE SHARED WITH THE EXECUTIVE COMMITTEE. ANY BOARD MEMBER WHO HAS A CONFLICT OF INTEREST IS EXCLUDED FROM VOTING ON ANY ISSUE INVOLVING THE CONFLICT OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 USING COMPARABILITY DATA SOURCED FROM AN INDEPENDENT ORGANIZATION, A BOARD OF TRUSTEES' COMPENSATION COMMITTEE REVIEWS THE PERFORMANCE AND ESTABLISHES THE ANNUAL COMPENSATION FOR THE CHIEF EXECUTIVE OFFICER. COMPENSATION DECISIONS ARE DETERMINED BY TAKING INTO CONSIDERATION THE FAIR MARKET RANGE FOR THE INDUSTRY. ALL COMMITTEE DISCUSSIONS ARE DOCUMENTED IN BOARD MINUTES. THE PRESIDENT DETERMINES THE COMPENSATION ANNUALLY FOR ALL OTHER EMPLOYEES, INCLUDING OFFICERS AND KEY EMPLOYEES, BASED ON PERFORMANCE APPRAISALS AND REVIEWS. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XI, LINE 9: CHANGE IN VALUE OF SPLIT-INTEREST AGREEMENTS 60,622. CHANGE IN VALUE OF FUTURE BUILDING OCCUPANCY -81,072. CHANGE IN FAIR VALUE OF DERIVATIVE FINANCIAL INSTRUMENT 87,973. CORIELL LIFE SCIENCE EXPENSES -599,948. CORIELL LIFE SCIENCES 403 HADDON AVENUE CAMDEN NJ 08103 461794812 GENETIC DATA STORAGE AND INTERPRETATION DE CORIELL INSTITUTE FOR MEDICAL RESEARCH C -513167 513167 0.67000 1 0 0 0 1 0 0 0 0 0 0 1 0 1 1 1 0 1 0 0 CORIELL LIFE SCIENCES D 599948 COST